GHCL has announced a conference call with MD R.S. Jalan and CFO Raman Chopra to discuss Q4FY25 business updates and financial results. Q4 revenue was Rs. 807 Cr, down 4% YoY, while EBITDA rose 22% YoY to Rs. 244 Cr, with margin expanding to 30.2%. PAT increased 23% to Rs. 153 Cr. FY25 EBITDA grew 7% to Rs. 966 Cr (29.5% margin), supported by volume growth and cost efficiencies. Capex continues with Vacuum Salt and Bromine projects on track for FY26. Domestic demand remains strong, with management confident about sustainable growth despite external challenges.